Kelsee

Dienogest/Ethinylestradiol, the active ingredient in Kelsee, is a combined oral contraceptive presented as an oral tablet for oral use. It prevents pregnancy in women of reproductive age by inhibiting ovulation and providing estrogenic support. GNH USA supplies Kelsee as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kelsee, a combined hormonal contraceptive, acts on the reproductive endocrine pathway to prevent pregnancy and manage related conditions.

Contraception: Prevents unintended pregnancy in women of childbearing age. Menstrual cycle regulation: Helps achieve more predictable and lighter menstrual bleeding. Acne management: Reduces androgen‑related acne in women using hormonal control.

Common Side Effects: - Nausea or gastrointestinal discomfort - Breast tenderness or enlargement - Headache or migraine - Weight gain or fluid retention - Mood swings or irritability - Spotting or breakthrough bleeding

Serious or Rare Side Effects: - Venous thromboembolism (deep‑vein thrombosis, pulmonary embolism) - Arterial thrombosis (stroke, myocardial infarction) - Severe hypertension or hypertensive crisis - Liver tumor or severe hepatic dysfunction - Anaphylaxis or severe allergic reaction - Visual disturbances or sudden vision loss

Before initiating Kelsee, consider the following precautions: - Cardiovascular risk assessment: evaluate history of thromboembolic events. - Smoking cessation: avoid use in women over 35 who smoke. - Liver function monitoring: contraindicated in active hepatic disease. - Pregnancy testing: ensure patient is not pregnant before starting. - Concomitant medication review: assess for interactions that may reduce efficacy. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine) may markedly reduce contraceptive effectiveness. - Anticoagulants (e.g., warfarin) can increase bleeding risk. - Certain antiretrovirals (e.g., protease inhibitors) may alter hormone levels.

Moderate Interactions (Monitor Closely): - Antibiotics such as tetracycline or fluoroquinolones may slightly decrease efficacy. - Herbal supplements like St. John’s wort can reduce plasma concentrations. - Anticonvulsants (e.g., phenytoin) may lower hormone levels. - Antihypertensives may require dose adjustment due to fluid retention. - Selective serotonin reuptake inhibitors may increase risk of serotonin syndrome when combined with hormonal therapy.